370 related articles for article (PubMed ID: 36160748)
1.
Wang S; Chen J; Guo XZ
World J Gastrointest Oncol; 2022 Aug; 14(8):1388-1405. PubMed ID: 36160748
[TBL] [Abstract][Full Text] [Related]
2. Roles of Autotaxin/Autotaxin-Lysophosphatidic Acid Axis in the Initiation and Progression of Liver Cancer.
She S; Zhang Q; Shi J; Yang F; Dai K
Front Oncol; 2022; 12():922945. PubMed ID: 35769713
[TBL] [Abstract][Full Text] [Related]
3. New insights into the autotaxin/LPA axis in cancer development and metastasis.
Leblanc R; Peyruchaud O
Exp Cell Res; 2015 May; 333(2):183-189. PubMed ID: 25460336
[TBL] [Abstract][Full Text] [Related]
4. Submucosal connective tissue-type mast cells contribute to the production of lysophosphatidic acid (LPA) in the gastrointestinal tract through the secretion of autotaxin (ATX)/lysophospholipase D (lysoPLD).
Mori K; Kitayama J; Aoki J; Kishi Y; Shida D; Yamashita H; Arai H; Nagawa H
Virchows Arch; 2007 Jul; 451(1):47-56. PubMed ID: 17554559
[TBL] [Abstract][Full Text] [Related]
5. Metabolomic Detection Between Pancreatic Cancer and Liver Metastasis Nude Mouse Models Constructed by Using the PANC1-KAI1/CD
Wang S; Chen J; Li H; Qi X; Liu X; Guo X
Technol Cancer Res Treat; 2021; 20():15330338211045204. PubMed ID: 34605330
[No Abstract] [Full Text] [Related]
6. Design and Development of Autotaxin Inhibitors.
Jia Y; Li Y; Xu XD; Tian Y; Shang H
Pharmaceuticals (Basel); 2021 Nov; 14(11):. PubMed ID: 34832985
[TBL] [Abstract][Full Text] [Related]
7. Autotaxin Implication in Cancer Metastasis and Autoimunne Disorders: Functional Implication of Binding Autotaxin to the Cell Surface.
Peyruchaud O; Saier L; Leblanc R
Cancers (Basel); 2019 Dec; 12(1):. PubMed ID: 31906151
[TBL] [Abstract][Full Text] [Related]
8. Regulation of tumor cell - Microenvironment interaction by the autotaxin-lysophosphatidic acid receptor axis.
Tigyi GJ; Yue J; Norman DD; Szabo E; Balogh A; Balazs L; Zhao G; Lee SC
Adv Biol Regul; 2019 Jan; 71():183-193. PubMed ID: 30243984
[TBL] [Abstract][Full Text] [Related]
9. Autotaxin/Lysophosphatidic Acid Axis: From Bone Biology to Bone Disorders.
Alioli C; Demesmay L; Peyruchaud O; Machuca-Gayet I
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408784
[TBL] [Abstract][Full Text] [Related]
10. CD82/KAI1 inhibits invasion and metastasis of esophageal squamous cell carcinoma via TGF-β1.
Zeng TD; Zheng B; Zheng W; Chen C
Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):5928-5937. PubMed ID: 30280774
[TBL] [Abstract][Full Text] [Related]
11. The Expression Regulation and Biological Function of Autotaxin.
Zhang X; Li M; Yin N; Zhang J
Cells; 2021 Apr; 10(4):. PubMed ID: 33921676
[TBL] [Abstract][Full Text] [Related]
12. The autotaxin-lysophosphatidic acid-lysophosphatidic acid receptor cascade: proposal of a novel potential therapeutic target for treating glioblastoma multiforme.
Tabuchi S
Lipids Health Dis; 2015 Jun; 14():56. PubMed ID: 26084470
[TBL] [Abstract][Full Text] [Related]
13. Cancer cell expression of autotaxin controls bone metastasis formation in mouse through lysophosphatidic acid-dependent activation of osteoclasts.
David M; Wannecq E; Descotes F; Jansen S; Deux B; Ribeiro J; Serre CM; Grès S; Bendriss-Vermare N; Bollen M; Saez S; Aoki J; Saulnier-Blache JS; Clézardin P; Peyruchaud O
PLoS One; 2010 Mar; 5(3):e9741. PubMed ID: 20305819
[TBL] [Abstract][Full Text] [Related]
14. ADSCs and adipocytes are the main producers in the autotaxin-lysophosphatidic acid axis of breast cancer and healthy mammary tissue in vitro.
Schmid R; Wolf K; Robering JW; Strauß S; Strissel PL; Strick R; Rübner M; Fasching PA; Horch RE; Kremer AE; Boos AM; Weigand A
BMC Cancer; 2018 Dec; 18(1):1273. PubMed ID: 30567518
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical detection of autotaxin (ATX)/lysophospholipase D (lysoPLD) in submucosal invasive colorectal cancer.
Kazama S; Kitayama J; Aoki J; Mori K; Nagawa H
J Gastrointest Cancer; 2011 Dec; 42(4):204-11. PubMed ID: 20623382
[TBL] [Abstract][Full Text] [Related]
16. Autotaxin in Pathophysiology and Pulmonary Fibrosis.
Ninou I; Magkrioti C; Aidinis V
Front Med (Lausanne); 2018; 5():180. PubMed ID: 29951481
[TBL] [Abstract][Full Text] [Related]
17. Role of Metastasis Suppressor KAI1/CD82 in Different Cancers.
Yan W; Huang J; Zhang Q; Zhang J
J Oncol; 2021; 2021():9924473. PubMed ID: 34306081
[TBL] [Abstract][Full Text] [Related]
18. [Clinical introduction of lysophosphatidic acid and autotaxin assays].
Yatomi Y
Rinsho Byori; 2010 Jun; 58(6):631-5. PubMed ID: 20662276
[TBL] [Abstract][Full Text] [Related]
19. Autotaxin induces lung epithelial cell migration through lysoPLD activity-dependent and -independent pathways.
Zhao J; He D; Berdyshev E; Zhong M; Salgia R; Morris AJ; Smyth SS; Natarajan V; Zhao Y
Biochem J; 2011 Oct; 439(1):45-55. PubMed ID: 21696367
[TBL] [Abstract][Full Text] [Related]
20. Phosphatase-resistant analogues of lysophosphatidic acid: agonists promote healing, antagonists and autotaxin inhibitors treat cancer.
Prestwich GD; Gajewiak J; Zhang H; Xu X; Yang G; Serban M
Biochim Biophys Acta; 2008 Sep; 1781(9):588-94. PubMed ID: 18454946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
